搜索筛选:
搜索耗时5.0836秒,为你在为你在102,285,761篇论文里面共找到 38 篇相符的论文内容
发布年度:
[期刊论文] 作者：Yi-Long Wu,
来源：四川生理科学杂志 年份：2021
Background:Osimertinib is standard-of-care therapy for previously untreated epidermal growth factor receptor(EGFR)mutation-positive advanced non-small-cell lung...
[期刊论文] 作者：Jin-Ji Yang,Yi-Long Wu,,
来源：Chinese Journal of Cancer 年份：2015
Introduction:Few data have been published comparing early-phase trials for lung cancer between China and the United States(US).This study was to investigate the...
[期刊论文] 作者：Tony S．Mok Yi-Long Wu Sumitra,
来源：中国处方药 年份：2009
背景及目的：之前的非对照研究表明，吉非替尼一线治疗对某些非小细胞肺癌患者有效，本研究比较了吉非替尼与卡铂-紫杉醇治疗肺腺癌的临床疗效。...
[会议论文] 作者：Feng Li,Wen-Zhao Zhong,Yi-Long Wu,
来源：2016第九届世界癌症大会 年份：2016
Background: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades.However,the clinical characteristics and prognosis of MPM patients involving lung cancer were n...
Specific TP53 Mutation Subtypes as Biomarker for Response to PD-1/L1 Blockade Immunotherapy in NSCLC
[会议论文] 作者：Hao Sun,Si-Yang Liu,Jia-Ying Zhou,Yi-Long Wu,
来源：2019中国肿瘤学大会 年份：2019
Objective The landscape of cancer therapy is currently being transformed by the recent clinical success of immunotherapies,and more particularly of those targeting the socalled immunotherapy checkpoin...
[会议论文] 作者：Binchao-Wang,Jin-ji Yang,Yisheng Huang,Zhang Wang,Yi-long Wu,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
...
[会议论文] 作者：Binchao-Wang,Jin-ji Yang,Yisheng Huang,Zhang Wang,Yi-long Wu,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
Objective: To analyze clinico-pathologic and genetic characteristics of EGFR-mutated lung cancer patients with progression from adenocarcinoma to small cell carcinoma after EGFR-TKI therapy....
[会议论文] 作者：Fei-Yu Niu,Qing Zhou,Zhi-hong Chen,Yan-Yan He,Wei Deng,Yi-long Wu,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
[期刊论文] 作者：Li Wen-peng,Wang Long-feng,Zhang Yi-long,Wu Li-jie,Zeng Long-mei,Tuo Zhong-sheng,
来源：China Geology 年份：2021
The surface watershed and groundwater basin have fixed recharge scale, which are not only the basic unit for hydrologic cycle research but also control the water resources formation and evolution and its corresponding eco-geological environ......
Met-positive (Met+), locally advanced or metastatic non-small cell lung cancer (NSCLC) with epiderma
[会议论文] 作者：Yi-Long Wu,Keunchil Park,Lianzhe Xu,Peiqi Li,Andreas Johne,James Chih-Hsin Yang,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Met-positive (Met+), locally advanced or metastatic non-small cell lung cancer (NSCLC) with epiderma
[会议论文] 作者：Yi-Long Wu,Keunchil Park,Lianzhe Xu,Peiqi Li,Andreas Johne,James Chih-Hsin Yang,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: A secondary mutation in the EGFR (ie, T790M) and amplification of the c-Met proto-oncogene are the main causes of resistance to EGFR tyrosine kinase inhibitors (eg, gefitinib) in EGFRm+ NSC...
[期刊论文] 作者：Hong-Xia Tian,Xu-Chao Zhang,Zhen Wang,Jian-Guang Chen,Shi-Liang Chen,Wei-Bang Guo,Yi-Long Wu,,
来源：Cancer Biology & Medicine 年份：2016
Objective: This study aims to establish a method for highly parallel multiplexed detection of genetic mutations in Chinese lung cancer samples through Agena i P...
Single-nucleotide polymorphisms in VTI1A gene contribute to the susceptibility to non-small cell lun
[会议论文] 作者：Wen-mei Su,Zhi-hong Chen,Xu-chao Zhang,Zhi Xie,Jian Su,Shi-liang Chen,Yi-long Wu,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Single-nucleotide polymorphisms in VTI1A gene contribute to the susceptibility to non-small cell lun
[会议论文] 作者：Wen-mei Su,Zhi-hong Chen,Xu-chao Zhang,Zhi Xie,Jian Su,Shi-liang Chen,Yi-long Wu,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: This study was to evaluate the association between single-nucleotide polymorphisms (SNP) in VTI1A gene and the susceptibility to lung cancer in never-smoking Chinese patients, and investiga...
Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients wi
[期刊论文] 作者：Xue-Ning Yang,Ling Huang,Yu Chen,She-Juan An,Xu-Chao Zhang,Ri-Qiang Liao,Jian Su,Yi-Long Wu,,
来源：Chinese Journal of Cancer Research 年份：2015
Background: Available study revealed advanced tumors have a higher expression rate of MAGE-A3 gene which has a lot of single nucleotide polymorphism(SNP) loci w...
EGFR amplification as a resistance mechanism to thirdgeneration EGFR TKI abivertinib and in vitro va
[会议论文] 作者：Yichen Zhang,Qing Zhou,Zhi-Hong Chen,Xu-Chao Zhang,Jian Su,Hao Sun,Si-Yang Liu,Yi-Long Wu,
来源：2019中国肿瘤学大会 年份：2019
Objective EGFR amplification was initially considered as a concurrent genomic altertions EGFR-mutant advanced non-small cell lung cancer(NSCLC),until the observation on the fact that amplification of...
[会议论文] 作者：Yi-Long Wu,Joo-Hang Kim,Sung-Hyun Yang,Li Zhang,Yuh-Min Chen,Chandra P Belani,Patrick Peterson,Mauro,
来源：第十四届全国临床肿瘤学大会暨2011年CSCO学术年会 年份：2011
...
Activity of the c-Met inhibitor tepotinib (MSC2156119J) in combination with gefitinib in Asian patie
[会议论文] 作者：Yi-long Wu,Keunchil Park,Dong-wan Kim,Ross a.Soo,Huiling Xiong,Cindy Li,Christian Ihling,James chih-hsin,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: c-Met abnormalities can cause resistance to EGFR TKIs in EGFR mutant NSCLC patients (pts).The highly selective c-Met inhibitor tepotinib (MSC2156...
[会议论文] 作者：She-Juan An,Zhi-Hong Chen,Wei Meng,Zhi Xie,Hong-hong Yan,Jian Su,Ying Huang,Shi-Liang Chen,Yi-Long Wu,
来源：第13届全国肺癌学术大会 年份：2013
...
[会议论文] 作者：Yi-Long Wu,Joo-Hang Kim,Sung-Hyun Yang,Li Zhang,Yuh-Min Chen,Chandra P Belani,Patrick Peterson,Mauro,
来源：第十四届全国临床肿瘤学大会暨2011年CSCO学术年会 年份：2011
Objective: In a previous randomized, placebo-controlled, multinational, phase 3 study, pemetrexed maintenance therapy prolonged progression-free survival (PFS) and overall survival (OS) in patients wi...
相关搜索：
